Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 18
Phase 214
Phase 33
Phase 43

Trial Status

Completed20
Other8

Role Distribution

Principal Investigator28
PI Rate100%

Activity Timeline

Clinical Trials (20)

NCT00000205Phase 3Completed
Buprenorphine Maintenance Protocol - 1
Opioid-Related Disorders
Principalinvestigator
NCT00000206Phase 2Completed
Clinical Rescue Protocol - 2
Opioid-Related Disorders
Principalinvestigator
NCT00000207Phase 3Completed
Multicenter Clinical Trial of Buprenorphine - 3
Opioid-Related Disorders
Principalinvestigator
NCT00000208Phase 2Completed
Methadone/Buprenorphine Cross-Over Study - 4
Opioid-Related Disorders
Principalinvestigator
NCT00000209Phase 2Completed
Buprenorphine Dosing Interval - 5
Opioid-Related Disorders
Principalinvestigator
NCT00000298Phase 2Completed
Buprenorphine Combination Tablet Feasibility - 1
Opioid-Related Disorders
Principalinvestigator
NCT00000299Phase 2Completed
Rapid Opiate Detoxification and Naltrexone Induction Using Buprenorphine - 2
Opioid-Related Disorders
Principalinvestigator
NCT00000300Phase 4Completed
Feasibility Study of Take-Home LAAM Medication - 3
Opioid-Related Disorders
Principalinvestigator
NCT00000301Phase 2Completed
Rapid Evaluation of Amantadine for Treatment of Cocaine Abuse/Dependence - 4
Cocaine-Related Disorders
Principalinvestigator
NCT00000302Phase 3Completed
Study Comparing Liquid and Tablet Buprenorphine Formulations - 5
Heroin Dependence
Principalinvestigator

Showing 10 of 20 trials

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Herbert Kleber, M.D.

New York State Psychiatric Institute

Related
9 trials

Shared therapeutic areas:

Cocaine-Related DisordersSubstance-Related DisordersHeroin Dependence+1 more

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score20%

Mark Greenwald, PhD

Wayne State University

Related
15 trials

Shared therapeutic areas:

Heroin DependenceOpioid-Related DisordersCocaine-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score15%

Thomas R Kosten, M.D.

VA Connecticut Healthcare System

Related
10 trials

Shared therapeutic areas:

Cocaine-Related DisordersOpioid-Related DisordersSubstance-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score15%

Dorothy Hatsukami, Ph.D.

University of Minnesota

Related
19 trials

Shared therapeutic areas:

Tobacco Use DisorderCocaine-Related DisordersSubstance-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score15%

Warren Bickel, Ph.D.

University of Vermont

Related
22 trials

Shared therapeutic areas:

Opioid-Related DisordersCocaine-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score10%

Eric C. Strain, MD

Johns Hopkins University

Related
9 trials

Shared therapeutic areas:

Opioid-Related DisordersCocaine-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score10%

Kenzie Preston, Ph.D.

National Institute on Drug Abuse (NIDA)

Related
9 trials

Shared therapeutic areas:

Opioid-Related DisordersCocaine-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score10%

David Fiellin, MD

Yale University

Related
7 trials

Shared therapeutic areas:

Opioid-Related DisordersSubstance-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score10%

James Zacny, Ph.D.

University of Chicago

Related
17 trials

Shared therapeutic areas:

Opioid-Related DisordersSubstance-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score10%

John R Knight, MD

Boston Children's Hospital

Related
9 trials

Shared therapeutic areas:

Substance-Related DisordersTobacco Use Disorder
Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (28)

Showing 20 of 28 trials

NCT00000205Phase 3PrincipalInvestigator

Buprenorphine Maintenance Protocol - 1

Opioid-Related Disorders
Completed
NCT00000206Phase 2PrincipalInvestigator

Clinical Rescue Protocol - 2

Opioid-Related Disorders
Completed
NCT00000207Phase 3PrincipalInvestigator

Multicenter Clinical Trial of Buprenorphine - 3

Opioid-Related Disorders
Completed
NCT00000208Phase 2PrincipalInvestigator

Methadone/Buprenorphine Cross-Over Study - 4

Opioid-Related Disorders
Completed
NCT00000209Phase 2PrincipalInvestigator

Buprenorphine Dosing Interval - 5

Opioid-Related Disorders
Completed
NCT00000298Phase 2PrincipalInvestigator

Buprenorphine Combination Tablet Feasibility - 1

Opioid-Related Disorders
Completed
NCT00000299Phase 2PrincipalInvestigator

Rapid Opiate Detoxification and Naltrexone Induction Using Buprenorphine - 2

Opioid-Related Disorders
Completed
NCT00000300Phase 4PrincipalInvestigator

Feasibility Study of Take-Home LAAM Medication - 3

Opioid-Related Disorders
Completed
NCT00000301Phase 2PrincipalInvestigator

Rapid Evaluation of Amantadine for Treatment of Cocaine Abuse/Dependence - 4

Cocaine-Related Disorders
Completed
NCT00000302Phase 3PrincipalInvestigator

Study Comparing Liquid and Tablet Buprenorphine Formulations - 5

Heroin Dependence
Completed
NCT00000303Phase 2PrincipalInvestigator

Rapid Evaluation of Baclofen for Treatment of Cocaine Abuse/Dependence - 6

Cocaine-Related Disorders
Completed
NCT00000320Phase 1/2PrincipalInvestigator

Buprenorphine Formulation Comparison: Sublingual Tablet vs. Solution - 1

Opioid-Related Disorders
Completed
NCT00000336Phase 2PrincipalInvestigator

Selegiline in Outpatient Treatment for Cocaine Dependence - 1

Cocaine-Related Disorders
Completed
NCT00000337Phase 1PrincipalInvestigator

Infusion Laboratory: Protocol 1 - Selegeline - 2

Cocaine-Related Disorders
Completed
NCT00000338Phase 1PrincipalInvestigator

Infusion Laboratory: Protocol 2 (Lisuride) - 3

Cocaine-Related Disorders
Unknown
NCT00000339Phase 1PrincipalInvestigator

Infusion Laboratory: Protocol 3 (Risperidone) - 4

Cocaine-Related Disorders
Unknown
NCT00000340Phase 2PrincipalInvestigator

Pemoline in the Treatment of Stimulant Dependence - 5

Cocaine-Related Disorders
Withdrawn
NCT00000341Phase 2PrincipalInvestigator

Evaluation of Liquid vs. Tablet Buprenorphine - 6

Opioid-Related Disorders
Completed
NCT00000342Phase 2PrincipalInvestigator

Risperidone for the Treatment of Cocaine Dependence - 7

Cocaine-Related Disorders
Completed
NCT00000343Phase 4PrincipalInvestigator

Brain Changes in Stimulant Dependent Subjects - 8

Substance-Related Disorders
Completed